Replies to post #44990 on RespireRx Pharmaceuticals Inc (RSPI)

[sharky]

$RSPI news: RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury

https://finance.yahoo.com/news/respirerx-pharmaceuticals-inc-reports-publication-123000336.html